HYSINGLA ER
Drug
Purdue Pharma L.P.
Total Payments
$1.2M
Transactions
24,371
Doctors
9,348
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $4,440 | 1 | 1 |
| 2020 | $49,943 | 1 | 0 |
| 2019 | $45,415 | 5 | 3 |
| 2018 | $69,250 | 231 | 226 |
| 2017 | $999,301 | 24,133 | 9,299 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $581,757 | 549 | 49.8% |
| Food and Beverage | $318,578 | 23,602 | 27.3% |
| Consulting Fee | $175,925 | 16 | 15.1% |
| Unspecified | $49,943 | 1 | 4.3% |
| Travel and Lodging | $41,297 | 201 | 3.5% |
| Space rental or facility fees (teaching hospital only) | $850.00 | 2 | 0.1% |
Payments by Type
General
$1.1M
24,370 transactions
Research
$49,943
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Hydrocodone ER Feasibility Pediatrics | Purdue Pharma L.P. | $49,943 | 0 |
Top Doctors Receiving Payments for HYSINGLA ER
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Winter Park, CO | $188,293 | 12 |
| , MD | Specialist | Charlotte, NC | $38,433 | 41 |
| , M.D | Interventional Pain Medicine | Newark, NJ | $38,301 | 43 |
| , MD, MS | Pain Medicine | San Francisco, CA | $36,456 | 37 |
| , MD | Anesthesiology | Boulder, CO | $29,725 | 49 |
| , M.D | Pain Medicine | Marietta, GA | $29,246 | 34 |
| , MD | Neuromusculoskeletal Medicine, Sports Medicine | Henderson, NV | $28,253 | 44 |
| , DO | Pain Medicine | Broken Arrow, OK | $27,581 | 33 |
| , M.D | Pain Medicine | Saint Louis, MO | $27,056 | 48 |
| , MD | Pain Medicine | Clinton Township, MI | $26,951 | 24 |
| , D.O | Anesthesiology | Honolulu, HI | $25,957 | 40 |
| , DO | Sports Medicine | Boise, ID | $25,356 | 34 |
| , M.D | Specialist | Pompano Beach, FL | $24,813 | 34 |
| , MD | Physical Medicine & Rehabilitation | Overland Park, KS | $24,361 | 22 |
| , M.D | Pain Medicine | Cuyahoga Falls, OH | $23,610 | 28 |
| , M.D | Family Medicine | Evansville, IN | $23,351 | 39 |
| , M.D | Specialist | Huntersville, NC | $22,602 | 27 |
| , MD | Physical Medicine & Rehabilitation | Arlington, VA | $20,229 | 38 |
| , M.D | Physical Medicine & Rehabilitation | Fairfield, CT | $18,416 | 16 |
| , D.O | Durable Medical Equipment & Medical Supplies | Terre Haute, IN | $17,571 | 35 |
| , MD | Pain Medicine | Fairless Hills, PA | $15,628 | 24 |
| , M.D | Physical Medicine & Rehabilitation | Pikesville, MD | $14,713 | 15 |
| , D.O | Physical Medicine & Rehabilitation | Elkins Park, PA | $12,832 | 15 |
| , MD | Internal Medicine | Newark, DE | $12,145 | 17 |
| , D.O | Physical Medicine & Rehabilitation | Newport Beach, CA | $11,829 | 19 |
Ad
Manufacturing Companies
- Purdue Pharma L.P. $1.2M
Product Information
- Type Drug
- Total Payments $1.2M
- Total Doctors 9,348
- Transactions 24,371
About HYSINGLA ER
HYSINGLA ER is a drug associated with $1.2M in payments to 9,348 healthcare providers, recorded across 24,371 transactions in the CMS Open Payments database. The primary manufacturer is Purdue Pharma L.P..
Payment data is available from 2017 to 2021. In 2021, $4,440 was paid across 1 transactions to 1 doctors.
The most common payment nature for HYSINGLA ER is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($581,757, 49.8% of total).
HYSINGLA ER is associated with 1 research study, including "Hydrocodone ER Feasibility Pediatrics" ($49,943).